Aqueous Tobacco Leaf Extract Injection for Dependence Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for tobacco dependence, primarily based on nicotine substitutes and bupropion, require long-term and multi-dose regimens, offering limited success rates and potential side effects, while homeopathic approaches lack demonstrated efficacy.
Innovation Solution
Aqueous extracts of tobacco leaves, administered as a sterile solution for injection, which can significantly reduce or eliminate tobacco dependence with a single or limited number of injections, targeting the neuromodulators dopamine, norepinephrine, and serotonin without inducing addiction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If nicotine substitutes (patches, gums, inhalers) are used to treat tobacco dependence, then withdrawal symptoms are relieved, but the treatment requires long-term multi-dose regimens with limited success rates (16-20% at one year)
Solution Approach 1:
The patent changes the concentration parameter by using a highly concentrated tobacco leaf extract (containing multiple active compounds at high concentrations) compared to the dilute nicotine substitutes currently used. This concentrated formulation delivers a therapeutic effect with a single injection, eliminating the need for long-term multi-dose regimens while achieving higher success rates (74% at one month, 53% at one year).
Solution Approach 2:
The patent uses a composite material approach by employing whole tobacco leaf extract that contains multiple active compounds (nicotine, anabasine, anatabine, and other alkaloids) working synergistically, rather than using isolated nicotine alone. This composite extract provides enhanced efficacy with a single administration, resolving the contradiction between treatment duration and success rate.
2Reliability
If bupropion (Zyban) is used to treat tobacco dependence, then the psychic component of addiction is addressed, but the treatment requires prescription and monitoring with potential serious side effects
Solution Approach 1:
The patent applies the principle of converting harm into benefit by using tobacco extract (the substance that causes addiction) in a controlled, concentrated formulation to treat the addiction itself. The high-dose tobacco extract produces a therapeutic effect that addresses both physical and psychic dependence, with a success rate of 74% at one month, while avoiding the serious side effects associated with bupropion.
3Object-affected harmful factors
If homeopathic tobacco extract is used, then the treatment is gentle and well-tolerated, but the efficacy is not demonstrated and success rates are insufficient
Solution Approach 1:
The patent applies partial or excessive action by using a high concentration of tobacco extract (excessive compared to homeopathic dilutions) to achieve a therapeutic threshold effect. The concentrated extract contains sufficient active compounds to produce a strong therapeutic response (74% success rate at one month) while remaining well-tolerated, thus achieving both high efficacy and good tolerability.
Data Source
AI summary
The invention relates to the use of an aqueous tobacco leaf extract for the preparation of a medicinal product for the treatment of dependence, particularly tobacco dependence, and to a sterile injection solution and a kit usable for the treatment of dependence, particularly of tobacco.